Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Booster”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05534035
What this trial is testing

Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older

Who this might be right for
SARS-CoV-2 Infection
Everest Medicines (Singapore) Pte. Ltd. 450
Very early researchLooking for participantsNCT07605520
What this trial is testing

An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines.

Who this might be right for
Healthy Adults
ANRS, Emerging Infectious Diseases 48
Not applicableStudy completedNCT05607082
What this trial is testing

COVID-19 Bivalent Booster Megastudy

Who this might be right for
COVID-19
University of Pennsylvania 2,600,000
Large-scale testing (Phase 3)Study completedNCT05710783
What this trial is testing

Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.

Who this might be right for
SARS-CoV-2 Infection
Laboratorio Avi-Mex, S.A. de C.V. 4,065
Not applicableStudy completedNCT05951920
What this trial is testing

Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine.

Who this might be right for
COVID-19
Assistance Publique - Hôpitaux de Paris 12
Testing effectiveness (Phase 2)UnknownNCT05109559
What this trial is testing

Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine

Who this might be right for
SARS-CoV-2 Infection
Mahidol University 690
Not applicableStudy completedNCT04993560
What this trial is testing

Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain

Who this might be right for
SARS-CoV 2 InfectionCovid19
Royal College of Surgeons in Ireland - Medical University of Bahrain 305
Testing effectiveness (Phase 2)Study completedNCT05525208
What this trial is testing

Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

Who this might be right for
COVID-19
PT Bio Farma 696
Testing effectiveness (Phase 2)Study completedNCT05727215
What this trial is testing

Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age

Who this might be right for
COVID-19
PT Bio Farma 150
Testing effectiveness (Phase 2)Study completedNCT05323435
What this trial is testing

Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV)

Who this might be right for
COVID-19
Jiangsu Rec-Biotechnology Co., Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT05672355
What this trial is testing

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaCOVID-19 Infection
City of Hope Medical Center 47
Not applicableStudy completedNCT05586204
What this trial is testing

Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up

Who this might be right for
COVID-19Vaccines
University of California, Los Angeles 154,977
Post-approval studies (Phase 4)UnknownNCT05095298
What this trial is testing

Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines

Who this might be right for
COVID-19
Huashan Hospital 400
Post-approval studies (Phase 4)UnknownNCT05079217
What this trial is testing

Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19

Who this might be right for
COVID-19
Sinovac Biotech Co., Ltd 1,200
Testing effectiveness (Phase 2)Study completedNCT05383560
What this trial is testing

Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults

Who this might be right for
COVID-19 PandemicImmunogenicitySARS CoV 2 Infection+1 more
Sheba Medical Center 179
Testing effectiveness (Phase 2)Study completedNCT07408297
What this trial is testing

Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda

Who this might be right for
COVID -19SARS CoV 2 Infection
Victoria Biomedical Research Institute 1,919
Large-scale testing (Phase 3)Study completedNCT05047770
What this trial is testing

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,013
Testing effectiveness (Phase 2)Study completedNCT05205746
What this trial is testing

Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence

Who this might be right for
SARS CoV 2 Infection
Laboratorio Avi-Mex, S.A. de C.V. 158
Large-scale testing (Phase 3)WithdrawnNCT05545683
What this trial is testing

Safety and Immunogenicity of Inactivated Heterologous Booster Vaccination

Who this might be right for
COVID-19
Centro de Estudios en Infectogía Pediatrica
Testing effectiveness (Phase 2)UnknownNCT05200741
What this trial is testing

To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2

Who this might be right for
Covid19
The University of Hong Kong 150
Next Page